Form 4: IRADIMED CCO Converts RSUs, Sells Shares for Tax

IRADIMED Corp's Chief Commercial Officer, Jeff Chiprin, converted restricted stock units into common stock and sold a portion to cover tax obligations.

Summary

• Jeff Chiprin, Chief Commercial Officer of IRADIMED CORP (IRMD), engaged in an insider transaction on December 11, 2025.
• He converted 996 Restricted Stock Units (RSUs) into an equal number of common stock shares.
• Following the conversion, 309 shares of common stock were disposed of at a price of $97.38 per share to satisfy tax liabilities.
• After these transactions, Chiprin beneficially owns 687 shares of common stock directly.
• He also continues to beneficially own 1,994 Restricted Stock Units, which represent future common stock entitlements.

Sentiment

Score: 5

Explanation: The filing details a routine insider transaction involving the vesting of Restricted Stock Units and the subsequent sale of shares to cover tax obligations. This is a neutral event, neither indicating significant positive nor negative company performance or strategic shifts.

Positives

• The vesting of Restricted Stock Units indicates a routine component of executive compensation, aligning management interests with shareholder value over time.
• The conversion of RSUs into common stock increases the direct equity ownership of a key executive in the company.

Negatives

• A portion of the newly acquired common stock (309 shares) was sold to cover tax obligations, resulting in a reduction of direct share ownership.

Future Outlook

The remaining Restricted Stock Units held by the reporting person are scheduled to vest in two additional equal annual installments following the initial vesting on December 11, 2025.

Management Comments

• Restricted stock units convert into common stock on a one-for-one basis.
• The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan.
• The RSUs vest in three equal annual installments beginning on December 11, 2025, with the reporting person receiving common stock shares upon vesting.

Industry Context

This transaction is a routine insider filing common across publicly traded companies, reflecting the standard practice of executive compensation through equity awards like Restricted Stock Units. Such filings provide transparency into management's direct ownership changes.

Stakeholder Impact

• Shareholders: Provides transparency into executive compensation and changes in insider ownership, which is generally viewed positively for corporate governance.
• Employees: Reflects standard executive compensation practices, which can influence overall employee morale and retention strategies.

Next Steps

• Future vesting of the remaining 1,994 Restricted Stock Units in two equal annual installments.

Key Dates

Keywords

IRADIMED CORP, IRMD, Jeff Chiprin, Chief Commercial Officer, CCO, Form 4, Insider Transaction, Restricted Stock Units, RSU, Stock Vesting, Tax Withholding, Beneficial Ownership